CMPI.org

In the News

President’s Speech on Drug Pricing: Actions & Implications

05/11/2018 12:00 AM | CMPI

Will Targeting Drug Rebates Help Cut the Cost of Prescription Drugs?

05/07/2018 12:00 AM | CNBC

Peter Pitts on CNN: What happens to your DNA when you share it?

04/29/2018 12:00 AM | CNN International

Peter Pitts on CNN: Family tree websites help I.D. serial killer

04/28/2018 12:00 AM | CNN

It’s Time for the FDA To Embrace Digital Technology

04/11/2018 12:00 AM | Artvoice

Surgeon General advises more to carry NARCAN

04/05/2018 12:00 AM | i24NEWS

Advancing Drug Safety Through Prospective Pharmacovigilance

04/01/2018 12:00 AM | Therapeutic Innovation & Regulatory Science Journal

Understanding FDA's Blueprint for Transparency

03/26/2018 12:00 AM | Medical Marketing & Media

To cut drug prices, start with the facts

03/09/2018 12:00 AM | Deseret News

On Drug Prices, President Trump Knows Better Than Candidate Donald

03/09/2018 12:00 AM | Investor's Business Daily

The Solution to Drug Pricing? Don’t Fix the Blame, Fix the Problem.

03/06/2018 12:00 AM | Morning Consult

A new NAFTA deal must halt intellectual property theft

03/01/2018 12:00 AM | Washington Examiner

Value of Medicines: The value equation

02/16/2018 12:00 AM | PharmaLive

Trump’s FDA Pick Is Speeding Up New Drug Approvals

02/02/2018 12:00 AM | Newsweek

These Companies Want You to Sell Your DNA on the Internet

01/18/2018 12:00 AM | Gizmodo

How PBMs Affect Access and Affordability

12/20/2017 12:00 AM | CMPI & NCPA

Keynote Speech: A. Mark Fendrick, M.D.

12/20/2017 12:00 AM | CMPI & NCPA

Principles for PBM Reform and Patient Centered Prescription Drug Benefits

12/20/2017 12:00 AM | CMPI & NCPA

CMPI Report: Principles for Patient-Centered Prescription Drug Coverage

12/20/2017 12:00 AM | CMPI & NCPA

Patients vs PBMs: The Movie

07/14/2017 12:00 AM | CMPI

Previous
1
...
6
7
8
9
10
11
12
Next

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

The Journal of Clinical Investigation
08/17/2026 12:00 AM

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

CMPI
08/10/2026 12:00 AM

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

CMPI
02/03/2026 12:00 AM

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo... Read more

Read all News